SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor-treated and resistant tumor cells
deposit · 1 version · 1 paper
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor-treated and resistant tumor cells
| Kind | deposit |
| Organisms | Homo sapiens (human) |
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor-treated and resistant tumor cells
Versions
as deposited
released 2025-05-07
Where it lives:
- PRIDE · PXD054097
Deposited by (1)
- SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells (2025) peer-reviewed as deposited
Methods on these papers (1)
- pSILAC quantitative immunopeptidomics with Peptide-PRISM downstream-application
Taken from the describing links only, so a paper that merely ran a tool on this data does not make that tool a method of it.